Biotech · Private company
Solstice Neurosciences, LLC, a subsidiary of MDD US Operations, LLC
Track this companyFree. Adds Solstice Neurosciences, LLC, a subsidiary of MDD US Operations, LLC to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- Phase 2; High Dose MYOBLOC (20,000 Units)Phase 3 · SpasticityClinicalTrials.gov · fetched Nov 12, 2026
- Phase 2; Low Dose MYOBLOC (10,000 Units)Phase 3 · SpasticityClinicalTrials.gov · fetched Nov 12, 2026
- Phase 2; Low Dose MYOBLOC (15,000 Units)Phase 3 · SpasticityClinicalTrials.gov · fetched Nov 12, 2026
- Phase 3; MYOBLOCPhase 3 · SpasticityClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Efficacy and Safety Study of MYOBLOC® in the Treatment of Adult Upper Limb SpasticityPHASE2_PHASE3 · TERMINATED · started Nov 2, 2021ClinicalTrials.gov NCT04815967 · fetched Nov 12, 2026
- Efficacy and Safety Study of MYOBLOC® in the Treatment of Adult Lower Limb SpasticityPHASE2_PHASE3 · TERMINATED · started Dec 17, 2019ClinicalTrials.gov NCT04099667 · fetched Nov 12, 2026